Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

VSTM $1.57 0.1400 +9.79%
KPTI $9.43 0.7300 +8.39%
OMED $13.80 0.9000 +6.98%
CYTR $2.78 0.1800 +6.92%
RXDX $6.90 0.4300 +6.65%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

VRML $1.15 -0.1000 -8.00%
CTIX $1.59 -0.0700 -4.22%
CPXX $17.11 -0.7100 -3.98%
LXRX $12.93 -0.4400 -3.29%
FBIO $2.69 -0.0800 -2.89%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

Pfizer to Trial Triple-Combination Cancer Treatment

(Financial Times) May 9, 2016 - Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make up lost ground in the race to develop a new generation of “immunotherapy” medicines that turn the body into a weapon against tumors.
read article (paid subscription required) 

$8.9M Grant Funds Research On Treatment For One Of Deadliest Cancers

(MUSC) May 9, 2016 - The Hollings Cancer Center has received an $8.9 million grant from the National Cancer Institute to foster collaboration across clinical and laboratory research for the study of signaling in sphingolipids, a class of lipids involved in the growth of solid tumor cancers.
read article 

Stand Up To Cancer to Offer Training Modules for Nurses on Front Lines of Administering New Cancer Therapies

(SU2C) May 9, 2016 - In recognition of Nurses Appreciation Week, Stand Up To Cancer (SU2C) announces the development of a series of Certification for Nursing Education (CNE) training modules by experts from Boston College William F. Connell School of Nursing.
read press release 

Swiss Blood Test for Colorectal Cancer Joins Race of ‘Liquid Biopsies’

( May 9, 2016 - Novigenix has published a validation study of its molecular blood test (Colox) which can reliably detect colorectal cancer at an early stage. Is this the second-place diagnostic in the race for Colorectal cancer blood tests?
read article 

LabCorp Launches Colorectal Cancer Test, But Key Hurdles Remain

(Xconomy Wisconsin) May 9, 2016 — The market for colorectal cancer tests that are less cumbersome than colonoscopies is getting more crowded.
read article 

NantHealth's Cancer Profiling Test Receives Coverage from Three Self-Insured Employers

(GenomeWeb News) May 10, 2016 - NantHealth said today that three self-insured employers — Bank of America, Phoenix Children's Hospital, and Sanford Health — have agreed to cover its GPS Cancer test for some cancers.
read article 

Big Data’s Big Implications for Cancer Treatments

(Genetic Engineering & Biotechnology News) May 9, 2016 - Data mining unearths pathways and networks that yield clinical gold.
read article (free registration required) 

Researcher Under Fire For New Yorker Epigenetics Article

( May 9, 2016 - Scientists attack Siddhartha Mukherjee’s feature exploring gene regulation.
read article 

Letters to the Editor: What the Medicare Part B Prescription Pilot Doesn’t Address

(Washington Post) May 5, 2016 - The May 2 editorial “Drug money,” which endorsed the Obama administration’s proposed Medicare Part B pilot program, did a serious disservice to the patients whose health would be jeopardized by this misguided experiment.
read article (free registration required) 

South Africa Negotiating With Roche To Cut Cancer Drug Prices

(Reuters) May 10, 2016 - South Africa is in talks with pharmaceutical firm Roche to reduce the price of its breast cancer drug Herceptin, which cost 500,000 rand ($32,745) a year to treat one person and was unaffordable to most women, the health minister said on Tuesday.
read article 

Cumberland Pharmaceuticals Expands Into Cancer Drugs

(The Tennessean) May 10, 2016 - Cumberland Pharmaceuticals will bring a drug used to treat some side effects from cancer treatment back to the U.S. — and expands its portfolio into oncology medications — under an agreement with Clinigen Group.
read article 

Tolmar Wins FDA Approval for Eligard to Treat Advanced Prostate Cancer

(Pharmaceutical Business Review) May 9, 2016 - TOLMAR Pharmaceuticals has secured from FDA a label update for ELIGARD, indicated for the palliative treatment of advanced prostate cancer.
read article 

New Guidelines on Bladder Cancer Management: AUA/SUO

(Medscape Medical News) May 10, 2016 - New joint guidelines on the management of bladder cancer issued by the American Urological Association (AUA) and the Society of Urologic Oncology (SUO) validate many long-standing practices used in the management of superficial bladder cancer but also affirm the real benefits associated with newer technologies to better visualize bladder tumors.
read article (free registration required) 

TRACON Pharmaceuticals Announces Initiation of Dosing in a Phase 1/2 Neoadjuvant Study of TRC105 in Patients with Breast Cancer

(Yahoo! Finance) May 9, 2016 - TRACON Pharmaceuticals today announced that dosing has been initiated in a Phase 1/2 clinical trial evaluating TRC105 in combination with Afinitor® (everolimus), a mammalian target of rapamycin (mTOR) inhibitor, and Femara® (letrozole), an aromatase inhibitor, to treat patients with breast cancer prior to surgery.
read article 

Study ID's Microbiome Tied to Infectious Outcomes in AML Patients

(Monthly Prescribing Reference/HealthDay News) May 9, 2016 - For patients with acute myelogenous leukemia (AML) undergoing induction chemotherapy (IC), gastrointestinal microbiome composition is associated with infectious complications, according to a study published online May 3 in Cancer.
read article 

Scripps Florida Scientists Design Potent Therapeutic 'Warheads' That Target Cancer Cells

(TSRI) May 9, 2016 - In a pair of related studies, chemists from the Florida campus of The Scripps Research Institute (TSRI) have identified and designed dozens of molecular “warheads” that not only can detect a key biomarker of cancer, but also could be developed into a potent new class of drug candidates for a range of diseases.
read press release 

Research Discovers Mechanism That Causes Cancer Cells To Escape From The Immune System

(Texas A&M/Vital Records) May 9, 2016 - Researchers at the Texas A&M Health Science Center found that when cancer cells are able to block the function of a gene called NLRC5, they are able to evade the immune system and proliferate.
read article 

Experimental Therapy Halts Treatment-Resistant Brain Tumors

(Cincinnati Children’s) May 9, 2016 - Researchers report in the journal Cancer Cell an experimental therapy that in laboratory tests on human cells and mouse models stops aggressive, treatment-resistant and deadly brain cancers called glioblastoma and high-grade gliomas.
read press release 

Discovery of Lung Cancer Mutations Responsive to Targeted Therapies and to Immunotherapies

(ITMO University [St. Petersburg, Russia]) May 10, 2016 - A number of new driver mutations in lung cancer cells has been discovered that may be responsive to genomically targeted therapies and to immunotherapy.
read article 

Scripps Florida Scientists Pioneer a Breakthrough Approach to Breast Cancer Treatment

(TSRI) May 9, 2016 - In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.
read press release 

New Research Gives Deeper Understanding Of Why Some Breast Cancers Are Hard To Treat

(Cancer Research UK) May 10, 2016 - Scientists have unearthed crucial new genetic information about how breast cancer develops and the genetic changes which can be linked to survival, according to a Cancer Research UK-funded study published in Nature Communications today (Tuesday).
read press release 

Radiotherapy Halves Deaths From Prostate Cancer 15 Years After Diagnosis

(Umeå University [Umeå, Sweden]) May 9, 2016 - A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of death from prostate cancer 15 years after diagnosis. This according to a follow-up study recently published in the journal European Urology.
read press release 

Study Suggests Chemotherapy After Radical Prostatectomy May Benefit Men Who Are At High Risk for Relapse

(AUA) May 7, 2016 - Not all men with prostate cancer benefit from adjuvant chemotherapy after radical prostatectomy; however, African American men and men with a higher tumor stage may, according to a new U.S. Department of Veterans Affairs (VA) study featured at the 111th Annual Scientific Meeting of the American Urological Association (AUA).
read press release 

Could 'Breast Cancer Genes' Play Role in Prostate Cancer, Too?

(U.S. News & World Report/HealthDay News) May 9, 2016 - A man's risk of aggressive and lethal prostate cancer may be heavily influenced by gene mutations previously linked to breast and ovarian cancer in women, a trio of new studies suggests.
read article 

NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients

(TheStreet) May 9, 2016 - An experimental cancer vaccine developed by NewLink Genetics failed to prolong survival in patients with pancreatic cancer compared to a standard therapy, according to results from a phase III study disclosed Monday.
read article